European Programs

ERC and Horizon Europe

The European Union supports scientific excellence through several funding mechanisms, including grants from the European Research Council (ERC) and the Horizon Europe framework program.

ERC grants are among the most prestigious sources of funding in the world for basic and translational research. They enable researchers to pursue innovative projects through various programs designed for early-career researchers (Starting Grants), mid-career researchers (Consolidator Grants), and established researchers (Advanced Grants), as well as collaborative projects (Synergy Grants). 

Key Figures

  • 8

    projects funded by the European Research Council (ERC), including 3 Starting Grants, 2 Consolidator Grants, 1 Advanced Grant, and 2 Synergy Grants.

  • 3

    Horizon Europe projects coordinated by Gustave Roussy

ERC Grants

Logo ERC

ERC grants are among the most prestigious sources of funding in the world for basic and translational research. They enable researchers to pursue innovative projects through various programs designed for early-career researchers (Starting Grants), mid-career researchers (Consolidator Grants), and established researchers (Advanced Grants), as well as collaborative projects (Synergy Grants). 

 

ERC Starting Grants

Project Principal Investigator Objective
CHIC Elsa Bernard

To better understand the biological mechanisms involved in the development and progression of cancers, with the goal of identifying new diagnostic and therapeutic approaches.

More information on the CHIC project:

TARGETSWITCH Dr. Sophie Postel-Vinay

Study of mechanisms of resistance to cancer treatments and the identification of new vulnerabilities that can be exploited for therapeutic purposes

More information on TARGETSWITCH: 

TheranoImmuno Sub-NK Alexandre Detappe

Exploration of new approaches combining imaging, therapeutic targeting, and immunotherapy to improve the effectiveness of cancer treatments

 

ERC Consolidator Grants

Project Principal Investigator Objective
REGEM Nataliya Petryk

To better understand the mechanisms of genome replication and epigenetic information transmission, two processes that are essential in the onset and progression of cancers.

More information on REGEM: 

 

CANPLAST Luc Friboulet

A project focused on tumor plasticity and the mechanisms by which cancer cells adapt to targeted therapies—a major challenge in the fight against drug resistance.

More information on CANPLAST: 

ERC Advanced Grant

Project Principal Investigator Objective
MADCAM Prof. Laurence Zitvogel

To study the interactions between the immune system, the microbiome, and cancers in order to develop new immunotherapy strategies.

More information on MADCAM: 

ERC Synergy Grants

Project Principal Investigator Objective
TREATLIVMETS

Prof. Florent Ginhoux and Prof. Eric Vivier

Collaborative project with the University of Strasbourg, the CNRS, Inserm, the Gustave Roussy Foundation, and Aix-Marseille University

To better understand the immune microenvironment of liver metastases and develop innovative therapeutic approaches to improve their management.

More information on TREATLIVEMETS: